Bank of New York Mellon Corp

Bank

Position in IKT — Inhibikase Therapeutics, Inc.

CIK 1390777 NEW YORK, NY

Position in IKT

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$615,344

+$257,155 QoQ

Shares Held

303,126

+42.2% QoQ

Ownership

0.217%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#33

of 105 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 87% Shared 0% None 13%

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. IKT ranks #227 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,672,623	$830,842,010
2	REGN	Regeneron Pharmaceuticals, Inc.	758,492	$472,950,091
3	JAZZ	Jazz Pharmaceuticals plc	1,578,013	$380,253,782
4	ALNY	Alnylam Pharmaceuticals, Inc.	492,071	$148,128,128
5	INSM	INSMED Inc	1,312,756	$139,966,036
6	MRNA	Moderna, Inc.	1,701,675	$119,168,293
7	RVMD	Revolution Medicines, Inc.	601,056	$112,565,759
8	INCY	Incyte Corp	972,825	$110,279,435

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$615,344	303,126	+42.2%	Shares	Defined	2026-08-06
2026-03-31	$358,189	213,208	+55.1%	Shares	Defined	2026-05-05
2025-12-31	$281,843	137,485	-0.9%	Shares	Defined	2026-02-10
2025-09-30	$224,639	138,667	+4.7%	Shares	Defined	2025-11-03
2025-06-30	$258,322	132,473	+239.6%	Shares	Defined	2025-08-05
2023-03-31	$25,666	39,007	0.0%	Shares	Defined	2023-05-09
2022-12-31	$19,503	39,007	-0.8%	Shares	Defined	2023-02-14
2022-09-30	$35,773	39,312	0.0%	Shares	Defined	2022-11-14
2022-06-30	$29,208	39,312	-0.7%	Shares	Defined	2022-08-15
2022-03-31	$58,578	39,580	0.0%	Shares	Defined	2022-05-11
2021-12-31	$58,182	39,580	0.0%	Shares	Defined	2022-02-11
2021-09-30	$75,202	39,580	—	Shares	Defined	2021-11-18
No filing history on record for this holder in this stock.